Abstract
There is a distinct pattern of response to gonadotropin stimulation in some patients marked by high peak estradiol (E2) levels, multifollicular ovarians response, and elevated basal luteinizing hormone (LH)/follicle-stimulating hormone (FSH) ratios. We reviewed the stimulation profiles of five such high-responder patients who failed to conceive during in vitro fertilization with ovarian stimulation using pure FSH. All patients had baseline LH/FSH >1.5 and peak E2>800 pg/ml. One cycle was canceled prior to hCG administration because of marked ovarian response (E2>2500 pg/ml, multiple small follicles). In a subsequent cycle, all patients were pretreated with the gonadotropin releasing-hormone agonist (GnRHa) leuprolide acetete for 10–14 days prior to initiation of FSH for ovarian stimulation. Leuprolide was continued until the day of hCG administration. During cycles using GnRHa, there was a statistically significant decrease (P <0.05) in serum FSH on day 3 (<5 vs 8.3 mIU/ml), serum E2 on day 3 (14.6 vs 34.6 pg/ml), and peak serum E2 (1197.6 vs 1923.0 pg/ml). Patients during cycles with GnRHa had a greater number of preovulatory (8.6 vs 3.0) and total (12.4 vs 6.0) oocytes retrieved (P<0.05). The fertilization rate of preovulatory oocytes was also higher during cycles using GnRHa (83 vs 64%). Two pregnancies occurred in the cycles pretreated with GnRHa. These preliminary data indicate that in high-responder patients, a combination of GnRHa and pure FSH results in lower E2 levels during the stimulation cycle and a greater number of total and mature oocytes retrieved and fertilized.
Similar content being viewed by others
References
Shaw RE, Ndukwe G, Imoedemhe D, Burford G, Chan R: Stimulation of multiple follicular growth for in vitro fertilization by administration of pulsatile luteinizing hormonereleasing hormone during the midfollicular phase. Fertil Steril 1986;46:135–137
Jones HW Jr, Jones GS, Andrews MC, Acosta AA, Bundren C, Garcia J, Sandow B, Veeck L, Wilkes C, Witmyer J, Wortham JE, Wright G: The program for in vitro fertilization at Norfolk. Fertil Steril 1982;38:14–21
Jones GS, Acosta AA, Garcia JE, Bernardus RE, Rosenwaks Z: The effect of follicle-stimulating hormone without additional luteinizing hormone on follicular stimulation and oocyte development in normal ovulatory women. Fertil Steril 1985;43:696–702
Quigley MM, Schmidt CL, Beauchamp PS, Pace-Owens S, Berkowitz AS, Wolf DP: Enhanced follicular recruitment in an in vitro fertilization program: Clomiphene alone versus a clomiphene-human menopausal gonadotropin combination. Fertil Steril 1984;42:25–33
Muasher SJ: Stimulation protocols for patients with “atypical response.” Ann NY Acad Sci 1988;541:82–95
Kenigsberg D, Littman BA, Williams RF, Hodgen GD: Medical hypophysectomy. II. Variability of ovarian response to gonadotropin therapy. Fertil Steril 1984;42:116–126
Hodgen GD, Kenigsberg D, Collins FL, Schenken RS: Selection of the dominant ovarian follicle and hormonal enhancement of the natural cycle. Ann NY Acad Sci 1985;442:23–37
Veeck LL, Wortham JWE, Witmyer J, Sandow BA, Acosta AA, Garcia JE, Jones GS, Jones HW jr: Maturation and fertilization of morphologically immature human oocytes in a program of in vitro fertilization. Fertil Steril 1983;39:594–602
Muasher SJ, Garcia JE, Rosenwaks Z: The combination of follicle-stimulating hormone and human menopausal gonadotropin for the induction of multiple follicular maturation for in vitro fertilization. Fertil Steril 1985;44:62–69
Romeau A, Acosta A, Jones GS, Liu HC, Jones D: Is the multifollicular ovarian response to stimulation desirable in an IVF program? Rev Iberoam Fertil Reprod Hum 1989; 6:520–525
Russell JB, Polan ML, DeCherney AH: The use of pure follicle-stimulation hormone for ovulation induction in normal ovulatory women in an in vitro fertilization program. Fertil Steril 1986;45:829–833
Erickson GF: An analysis of follicle development and ovum maturation. Sem Reprod Endocrinol 1986;4:233–254
Erickson GF, Hsueh AJW, Quigley ME, Rebar RW, Yen SS: Functional studies of aromatase activity in human granulosa cells from normal and polycystic ovaries. J Clin Endocrinol Metab 1979;49:514–519
Raj SG, Berger MJ, Grimes EM, Taymor ML: The use of gonadotropins for the induction of ovulation in women with polycystic ovarian disease. Fertil Steril 1977;28:1280–1284
Seibel MM, McArdle C, Smith D, Taymor ML: Ovulation induction in polycystic ovary syndrome with urinary folliclestimulating hormone or human menopausal gonadotropin. Fertil Steril 1985;43:703–708
Venuroli S, Paradisi R, Fabbri R, Magrini O, Porcu E, Flamigni C: Comparison between human urinary follicle stimulating hormone and human menopausal gonadotropin treatment in polycystic ovary. Obstet Gynecol 1984;63:6–11
Charbonnel B, Krempf M, Blanchard P, Dano F, Delage C: Induction of ovulation in polycystic ovary syndrome with a combination of luteinizing hormone-releasing analog and exogenous gonadotropins. Fertil Steril 1987;47:920–924
Fleming R, Haxton MJ, Hamilton MPR, McCune GS, Black WP, Macnaughton MC, Coutis JRT: Succesful treatment of infertile women with oligomenorrhoea using a combination of an LHRH agonist and exogenous gonadotrophins. Br J Obstet Gynaecol 1985;92:369–373
de Ziegler D, Cedars MI, Randle D, Lu JKH, Judd HL, Meldrum DR: Suppression of the ovary using a gonadotropin-releasing hormone agonist prior to stimulation for oocyte retrieval. Fertil Steril 1987;48:807–810
Awadalla SG, Friedman CI, Chin NW, Dodds W, Park JM, Kim MH: Follicular stimulation for in vitro fertilization using pituitary suppression and human menopausal gonadotropins. Fertil Steril 1987;48:811–815
Meldrum DR, Tsao Z, Monroe GD, Braustein J, Sladek J, Lu JKH, Vale W, Rivier J, Judd HL, Chang RJ: Stimulation of LH fragments with reduced bioactivity following GnRH agonist administration in women. J Clin Endocrinol Metab 1984;58:755–757
Dahl KD, Pavlou SN, Kovacs WJ, Hsueh AJW: The changing ratio of serum bioactive to immunoreactive follicle-stimulating hormone in normal men following treatment with a potent gonadotropin releasing hormone antagonist. J Clin Endocrinol Metab 1986;63:792–794
Neveu S, Hedon B, Bringer J, Chinchole JM, Arnal F, Humeau C, Cristol P, Viala JL: Ovarian stimulation by a combination of a gonadotropin-releasing hormone agonist and gonadotropins for in vitro fertilization. Fertil Steril 1987;47:639–643
Droesch K, Muasher SJ, Brzyski RG, Jones GS, Simonetti S, Liu HC, Rosenwaks Z: Value of suppression with a gonadotropin-releasing hormone agonist prior to gonadotropin stimulation for in vitro fertilization. Fertil Steril 1989;51:292–297
Forman R, Fries N, Testart J, Belaisch-Allart J, Hazout A, Frydman R: Evidence for an adverse effect of elevated serum estradiol concentrations on embryo implantation. Fertil Steril 1988;49:118–122
Lejeune B, Degueldre M, Camus M, Vekemans M, Opsomer L, Leroy F: In vitro fertilization and embryo transfer as related to endogenous luteinizing hormone rise or human chorionic gonadotropin administration. Fertil Steril 1986;45:377–383
Stanger JD, Yovich JL: Reduced in-vitro fertilization of human oocytes from patients with raised basal luteinizing hormone levels during the follicular phase. Br J Obstet Gynaecol 1985;92:385–393
Moor RM, Trounson AO: Hormonal and follicular factors affecting maturation of sheep oocytes in vitro and their subsequent developmental capacity. J Reprod Fert 1977;49:101–109
Salat-Baroux J, Alvarez S, Antoine JM, Cornet D, Tibi C, Plachot M, Mandelbaum J: Results of IVF in the treatment of polycystic ovary disease. Hum Reprod 1988;3:331–335
Muasher SJ, Oehninger S, Simonetti S, Mata J, Ellis LM, Liu HC, Jones GS, Rosenwaks Z: The value of basal and/or stimulated serum gonadotropin levels in prediction of stimulation response and in vitro fertilization outcome. Fertil Steril 1988;50:298–307
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Edelstein, M.C., Brzyski, R.G., Jones, G.S. et al. Ovarian stimulation for in vitro fertilization using pure follicle-stimulating hormone with and without gonadotropin-releasing hormone agonist in high-responder patients. J Assist Reprod Genet 7, 172–176 (1990). https://doi.org/10.1007/BF01135684
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01135684